Literature DB >> 22739293

Influenza: Five questions on H5N1.

Ed Yong.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22739293     DOI： 10.1038/486456a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  10 in total

1.  The potential for respiratory droplet-transmissible A/H5N1 influenza virus to evolve in a mammalian host.

Authors:  Colin A Russell; Judith M Fonville; André E X Brown; David F Burke; David L Smith; Sarah L James; Sander Herfst; Sander van Boheemen; Martin Linster; Eefje J Schrauwen; Leah Katzelnick; Ana Mosterín; Thijs Kuiken; Eileen Maher; Gabriele Neumann; Albert D M E Osterhaus; Yoshihiro Kawaoka; Ron A M Fouchier; Derek J Smith
Journal:  Science       Date:  2012-06-22       Impact factor: 47.728

2.  Airborne transmission of influenza A/H5N1 virus between ferrets.

Authors:  Sander Herfst; Eefje J A Schrauwen; Martin Linster; Salin Chutinimitkul; Emmie de Wit; Vincent J Munster; Erin M Sorrell; Theo M Bestebroer; David F Burke; Derek J Smith; Guus F Rimmelzwaan; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  Science       Date:  2012-06-22       Impact factor: 47.728

3.  Evidence for differing evolutionary dynamics of A/H5N1 viruses among countries applying or not applying avian influenza vaccination in poultry.

Authors:  Giovanni Cattoli; Alice Fusaro; Isabella Monne; Fethiye Coven; Tony Joannis; Hatem S Abd El-Hamid; Aly Ahmed Hussein; Claire Cornelius; Nadim Mukhles Amarin; Marzia Mancin; Edward C Holmes; Ilaria Capua
Journal:  Vaccine       Date:  2011-10-12       Impact factor: 3.641

4.  Seroevidence for H5N1 influenza infections in humans: meta-analysis.

Authors:  Taia T Wang; Michael K Parides; Peter Palese
Journal:  Science       Date:  2012-02-23       Impact factor: 47.728

5.  High level of genetic compatibility between swine-origin H1N1 and highly pathogenic avian H5N1 influenza viruses.

Authors:  Cássio Pontes Octaviani; Makoto Ozawa; Shinya Yamada; Hideo Goto; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

6.  Increased pathogenicity of a reassortant 2009 pandemic H1N1 influenza virus containing an H5N1 hemagglutinin.

Authors:  Troy D Cline; Erik A Karlsson; Pamela Freiden; Bradley J Seufzer; Jerold E Rehg; Richard J Webby; Stacey Schultz-Cherry
Journal:  J Virol       Date:  2011-09-14       Impact factor: 5.103

7.  Characterization of the influenza A virus gene pool in avian species in southern China: was H6N1 a derivative or a precursor of H5N1?

Authors:  E Hoffmann; J Stech; I Leneva; S Krauss; C Scholtissek; P S Chin; M Peiris; K F Shortridge; R G Webster
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

8.  IFITM3 restricts the morbidity and mortality associated with influenza.

Authors:  Aaron R Everitt; Simon Clare; Thomas Pertel; Sinu P John; Rachael S Wash; Sarah E Smith; Christopher R Chin; Eric M Feeley; Jennifer S Sims; David J Adams; Helen M Wise; Leanne Kane; David Goulding; Paul Digard; Verneri Anttila; J Kenneth Baillie; Tim S Walsh; David A Hume; Aarno Palotie; Yali Xue; Vincenza Colonna; Chris Tyler-Smith; Jake Dunning; Stephen B Gordon; Rosalind L Smyth; Peter J Openshaw; Gordon Dougan; Abraham L Brass; Paul Kellam
Journal:  Nature       Date:  2012-03-25       Impact factor: 49.962

9.  Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets.

Authors:  Masaki Imai; Tokiko Watanabe; Masato Hatta; Subash C Das; Makoto Ozawa; Kyoko Shinya; Gongxun Zhong; Anthony Hanson; Hiroaki Katsura; Shinji Watanabe; Chengjun Li; Eiryo Kawakami; Shinya Yamada; Maki Kiso; Yasuo Suzuki; Eileen A Maher; Gabriele Neumann; Yoshihiro Kawaoka
Journal:  Nature       Date:  2012-05-02       Impact factor: 49.962

10.  Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia.

Authors:  Menno D de Jong; Cameron P Simmons; Tran Tan Thanh; Vo Minh Hien; Gavin J D Smith; Tran Nguyen Bich Chau; Dang Minh Hoang; Nguyen Van Vinh Chau; Truong Huu Khanh; Vo Cong Dong; Phan Tu Qui; Bach Van Cam; Do Quang Ha; Yi Guan; J S Malik Peiris; Nguyen Tran Chinh; Tran Tinh Hien; Jeremy Farrar
Journal:  Nat Med       Date:  2006-09-10       Impact factor: 53.440
  10 in total
  6 in total

1.  Avian influenza A(H5N1) and A(H9N2) seroprevalence and risk factors for infection among Egyptians: a prospective, controlled seroepidemiological study.

Authors:  Mokhtar R Gomaa; Ahmed S Kayed; Mona A Elabd; Dina Abu Zeid; Shaimaa A Zaki; Amira S El Rifay; Lobna S Sherif; Pamela P McKenzie; Robert G Webster; Richard J Webby; Mohamed A Ali; Ghazi Kayali
Journal:  J Infect Dis       Date:  2014-10-29       Impact factor: 5.226

2.  Intrasubtype reassortments cause adaptive amino acid replacements in H3N2 influenza genes.

Authors:  Alexey D Neverov; Ksenia V Lezhnina; Alexey S Kondrashov; Georgii A Bazykin
Journal:  PLoS Genet       Date:  2014-01-09       Impact factor: 5.917

3.  Advances in Antiviral Material Development.

Authors:  Lili Liang; Ashiq Ahamed; Liya Ge; Xiaoxu Fu; Grzegorz Lisak
Journal:  Chempluschem       Date:  2020-08-21       Impact factor: 3.210

Review 4.  Systems approaches to influenza-virus host interactions and the pathogenesis of highly virulent and pandemic viruses.

Authors:  Marcus J Korth; Nicolas Tchitchek; Arndt G Benecke; Michael G Katze
Journal:  Semin Immunol       Date:  2012-12-05       Impact factor: 11.130

Review 5.  Influenza B-cells protective epitope characterization: a passkey for the rational design of new broad-range anti-influenza vaccines.

Authors:  Nicola Clementi; Elena Criscuolo; Matteo Castelli; Nicasio Mancini; Massimo Clementi; Roberto Burioni
Journal:  Viruses       Date:  2012-11-14       Impact factor: 5.048

Review 6.  Viral pathogens and acute lung injury: investigations inspired by the SARS epidemic and the 2009 H1N1 influenza pandemic.

Authors:  Carolyn M Hendrickson; Michael A Matthay
Journal:  Semin Respir Crit Care Med       Date:  2013-08-11       Impact factor: 3.119
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.